The beginning of a new era in induction treatment for operable non-small cell lung cancer: a narrative review.

Shinohara, Shuichi; Takahashi, Yusuke; Masago, Katsuhiro; Matsushita, Hirokazu; Kuroda, Hiroaki

Shinohara, Shuichi; Takahashi, Yusuke; Masago, Katsuhiro; Matsushita, Hirokazu; Kuroda, Hiroaki.

Afiliación

Shinohara S; Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
Takahashi Y; Division of Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Masago K; Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
Matsushita H; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.
Kuroda H; Division of Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan.

J Thorac Dis ; 15(2): 747-758, 2023 Feb 28.

Article en En | MEDLINE | ID: mdl-36910085

Palabras clave

Non-small cell lung cancer (NSCLC); immune checkpoint inhibitor (ICI); induction; neoadjuvant; randomized control study

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Thorac Dis Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google